pd 98059 has been researched along with Hepatoblastoma in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Hepatoblastoma: A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Hu, S | 1 |
| Zhang, Z | 1 |
| Qian, L | 1 |
| Xue, Q | 1 |
| Qu, X | 1 |
| Tomizawa, M | 1 |
| Saisho, H | 1 |
2 other studies available for pd 98059 and Hepatoblastoma
| Article | Year |
|---|---|
LASP2 is downregulated in human liver cancer and contributes to hepatoblastoma cell malignant phenotypes through MAPK/ERK pathway.
Topics: Carrier Proteins; Cell Movement; Cytoskeletal Proteins; Down-Regulation; Female; Flavonoids; Gene Ex | 2020 |
Signaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma.
Topics: Androstadienes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromones; Enzyme Inhibitors; Flavo | 2006 |